Pancreas and islet cell transplantation.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3184836)

Published in Best Pract Res Clin Gastroenterol on June 01, 2002


Rita Bottino1, Massimo Trucco, A N Balamurugan, Thomas E Starzl

Author Affiliations

1: Division of Immunogenetics, Diabetes Institute, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA.

Articles cited by this

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26

The fate of skin homografts in man. J Anat (1943) 17.30

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Automated method for isolation of human pancreatic islets. Diabetes (1988) 8.23


The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med (1997) 7.65

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med (1998) 6.13

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med (1963) 5.14

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care (1998) 4.49

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A (2000) 3.80

Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med (2000) 3.79

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81

Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes (2000) 2.70

Diabetes in America: epidemiology and scope of the problem. Diabetes Care (1998) 2.68

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation (1995) 2.67

Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery (1967) 2.49

Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation (1991) 2.32

Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25

Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities? N Engl J Med (1992) 2.17

Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89

Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59

Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57

Cell loss in isolated human islets occurs by apoptosis. Pancreas (2000) 1.45

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia (1998) 1.44

Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem (2000) 1.42

Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature (1973) 1.42

Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34

Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest (1990) 1.26

Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg (1999) 1.24

Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes (2002) 1.23

Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18

Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes (1990) 1.17

Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation (1999) 1.16

Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg (1998) 1.16

Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: a computer-assisted intravital microscopy study on the conjunctival microcirculation. Transplantation (1999) 1.15

Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol (1999) 1.14

Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation (1999) 1.10

Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage. Surgery (1973) 1.08

The cost of diabetes and diabetes care. Diabetes Res Clin Pract (2001) 1.07


Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation (1997) 1.05

Quadruple immunosuppressive therapy in whole pancreas transplantation. Transplant Proc (1987) 1.03

Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes (1997) 0.99

Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes (1997) 0.99

Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant (1999) 0.98

Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg (1996) 0.98

The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes (1997) 0.97

Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation. Diabetes Metab (2000) 0.96

Successful autotransplantation of isolated islets of Langerhans in the cynomolgus monkey. Br J Surg (1986) 0.93

Isolation, culture and functional evaluation of islets of Langerhans. Diabetes Metab (1998) 0.92

Metabolic and morphologic studies in intraportal-islet-transplanted rats. Diabetes (1976) 0.92

A new site for islet transplantation--a peritoneal-omental pouch. Transplantation (1983) 0.92

Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene. Transplantation (2000) 0.91

History of clinical transplantation. World J Surg (2000) 0.91

Targeting autoimmune diabetes with gene therapy. Diabetes (1999) 0.89

Number and volume of islets transplanted in immunobarrier devices. Cell Transplant (1998) 0.87

Metabolic effects of urinary diversion of exocrine secretions in pancreatic transplantation. Transplantation (1987) 0.87

A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage. Ann Surg (2001) 0.86

Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes (1992) 0.86

Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. Ann Surg (1999) 0.84

Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia. Diabetes (1994) 0.82

Successful islet/abdominal testis transplantation does not require Leydig cells. Transplantation (1990) 0.80

Islet cryopreservation protocols. Ann N Y Acad Sci (1999) 0.79

Intrapancreatic islet transplantation in experimental diabetes in the rat. Metabolism (1992) 0.78

Submucosal transplantation of pancreatic islets. Transplant Proc (1994) 0.77

Outcome of 300 consecutive pancreas-kidney transplants. Transplant Proc (1998) 0.77

Xenogeneic islet transplantation. Xenotransplantation (1999) 0.77

Clinical aspects and perspectives in islet xenotransplantation. J Hepatobiliary Pancreat Surg (2000) 0.77

Experience with 100 combined pancreatic renal transplantations in a single center. Nephron (1996) 0.77

Quality of life in type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function. Diabetologia (1991) 0.76

Application of AN69 hydrogel to islet encapsulation. Evaluation in streptozotocin-induced diabetic rat model. Ann N Y Acad Sci (1997) 0.76

Bulk cryopreservation of isolated islets of Langerhans. Cell Transplant (1996) 0.75

Articles by these authors

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96

On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am J Hum Genet (2008) 3.95

Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07

Screen and clean: a tool for identifying interactions in genome-wide association studies. Genet Epidemiol (2010) 2.70


A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol (2007) 2.23


Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes (2004) 2.16

Factors associated with islet yield and insulin independence after total pancreatectomy and islet cell autotransplantation in patients with chronic pancreatitis utilizing off-site islet isolation: Cleveland Clinic experience. J Clin Endocrinol Metab (2015) 2.14

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant (2012) 2.12

Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg (2012) 2.00

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol (2011) 1.93

Clinical xenotransplantation: the next medical revolution? Lancet (2011) 1.84

Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes (2004) 1.81

Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation (2008) 1.80

The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75

Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73

Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J (2009) 1.70

Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem (2009) 1.69

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant (2008) 1.68

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care (2011) 1.65

Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes (2005) 1.64

Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol (2002) 1.63

Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61


HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol (2006) 1.58

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond. Pediatr Diabetes (2008) 1.50

Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes (2006) 1.49

Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46

Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. Diabetes (2006) 1.45

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43

Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42

Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol (2008) 1.38


Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30

Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice. Diabetes (2005) 1.27

Clinical islet xenotransplantation: how close are we? Diabetes (2012) 1.26

Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24

Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes (2002) 1.23

Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol (2011) 1.21

Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21

Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J Immunol (2007) 1.19

Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia (2007) 1.19

Human islet isolation for autologous transplantation: comparison of yield and function using SERVA/Nordmark versus Roche enzymes. Am J Transplant (2009) 1.18

Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18

Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18

Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes (2002) 1.17

Prediction of pancreatic tissue densities by an analytical test gradient system before purification maximizes human islet recovery for islet autotransplantation/allotransplantation. Transplantation (2011) 1.17

Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis (2008) 1.17

Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol (2004) 1.16

Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes (2003) 1.15

The role of external and matrix pH in mitochondrial reactive oxygen species generation. J Biol Chem (2008) 1.13

Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J Biol Chem (2003) 1.12

OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11

Using ancestry matching to combine family-based and unrelated samples for genome-wide association studies. Stat Med (2010) 1.11

Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One (2010) 1.10

Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells. Diabetes (2006) 1.10

Bistability of mitochondrial respiration underlies paradoxical reactive oxygen species generation induced by anoxia. PLoS Comput Biol (2009) 1.10

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10

Footer: a quantitative comparative genomics method for efficient recognition of cis-regulatory elements. Genome Res (2005) 1.09

Immunosuppressive effects of glucosamine. J Biol Chem (2002) 1.08

Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes (2003) 1.08

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells (2003) 1.07

Suppression of autoimmune diabetes by soluble galectin-1. J Immunol (2009) 1.06

Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol (2008) 1.04

The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant (2005) 1.02

Body window-enabled in vivo multicolor imaging of transplanted mouse islets expressing an insulin-Timer fusion protein. Biotechniques (2003) 1.02

Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies. Xenotransplantation (2007) 1.02

Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation. Am J Transplant (2005) 1.01

Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis. Pediatr Diabetes (2009) 1.01

Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors. Gene Ther (2005) 1.01

A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes. Diabetes (2008) 1.01

No islets left behind: islet autotransplantation for surgery-induced diabetes. Curr Diab Rep (2012) 1.01

Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants. Transplantation (2011) 0.99

Reduction of early graft loss after intraportal porcine islet transplantation in monkeys. Transplantation (2007) 0.99

Total pancreatectomy and islet autotransplantation in children for chronic pancreatitis: indication, surgical techniques, postoperative management, and long-term outcomes. Ann Surg (2014) 0.98

Redox modulation protects islets from transplant-related injury. Diabetes (2010) 0.98

Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J Immunol (2006) 0.98

Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells. Diabetes (2010) 0.97

Humoral Antibodies in Patients After Renal Homotransplantation. Transplantation (1967) 0.96

Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant (2001) 0.96

Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95

Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation. Am J Transplant (2014) 0.95

Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. Pancreas (2006) 0.95

Severely fibrotic pancreases from young patients with chronic pancreatitis: evidence for a ductal origin of islet neogenesis. Acta Diabetol (2011) 0.95